BRPI0407410A - método para o tratamento de hipotireoidismo - Google Patents

método para o tratamento de hipotireoidismo

Info

Publication number
BRPI0407410A
BRPI0407410A BRPI0407410-6A BRPI0407410A BRPI0407410A BR PI0407410 A BRPI0407410 A BR PI0407410A BR PI0407410 A BRPI0407410 A BR PI0407410A BR PI0407410 A BRPI0407410 A BR PI0407410A
Authority
BR
Brazil
Prior art keywords
hypothyroidism
treating hypothyroidism
treatment
treating
adult
Prior art date
Application number
BRPI0407410-6A
Other languages
English (en)
Inventor
Irwin Klein
Kaie Ojamaa
Sara Danzi
Original Assignee
Long Island Jewish Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Long Island Jewish Res Inst filed Critical Long Island Jewish Res Inst
Publication of BRPI0407410A publication Critical patent/BRPI0407410A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"MéTODO PARA O TRATAMENTO DE HIPOTIREOIDISMO". A presente invenção proporciona um método para o tratamento de hipotireoidismo em um adulto compreendendo a administração a longo prazo de T~ 3~ em uma dose de 0,005-0,03 <109>g/kg de peso corporal/hora/dia.
BRPI0407410-6A 2003-02-11 2004-02-06 método para o tratamento de hipotireoidismo BRPI0407410A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/364,800 US20040156893A1 (en) 2003-02-11 2003-02-11 Method for treating hypothyroidism
PCT/US2004/003620 WO2004071432A2 (en) 2003-02-11 2004-02-06 Method for treating hypothyroidism

Publications (1)

Publication Number Publication Date
BRPI0407410A true BRPI0407410A (pt) 2006-02-21

Family

ID=32824502

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407410-6A BRPI0407410A (pt) 2003-02-11 2004-02-06 método para o tratamento de hipotireoidismo

Country Status (9)

Country Link
US (2) US20040156893A1 (pt)
EP (1) EP1599193A4 (pt)
JP (1) JP2006517588A (pt)
AU (1) AU2004211961B2 (pt)
BR (1) BRPI0407410A (pt)
CA (1) CA2515400A1 (pt)
CO (1) CO5650242A2 (pt)
NO (1) NO20054034L (pt)
WO (1) WO2004071432A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
US10150792B2 (en) * 2010-11-08 2018-12-11 Synthonics, Inc. Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
US10695309B2 (en) 2017-03-31 2020-06-30 Western New England University Sustained-release liothyronine formulations, method of preparation and method of use thereof
WO2021237048A1 (en) * 2020-05-21 2021-11-25 Equilibrate Therapeutics, LLC Microneedle device for control of thyroid hormone levels
US12451021B2 (en) 2022-08-04 2025-10-21 The Mitre Corporation Microscale weather hazard products for urban aviation transportation
CN120475952A (zh) * 2022-12-08 2025-08-12 发道支付有限责任公司 用于治疗和预防脱发和头发花白的局部组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577535A (en) * 1966-06-29 1971-05-04 Armour Pharma Treatment of thyroid hormone impairment pharmaceutical compositions containing 3,5,3' -l-triiodothyronine complexes
US3477954A (en) * 1966-06-29 1969-11-11 Armour Pharma Phosphonium iodide complexes of thyroxine,methods of preparing same,and methods of preparing 3,5,3'-l-triiodothyronine therefrom
US3621096A (en) * 1969-04-03 1971-11-16 Univ North Carolina Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
US3689669A (en) * 1970-10-09 1972-09-05 Univ Of North Carolina The Antidepressant method and composition
US3928553A (en) * 1972-03-23 1975-12-23 Univ New York Radioimmunoassay method for triiodothyronine and thyroxine
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
ATE164063T1 (de) * 1991-12-30 1998-04-15 Akzo Nobel Nv Thyroaktive zusammensetzung mit kontrollierter freigabe
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
US6288117B1 (en) * 2000-03-23 2001-09-11 North Shore-Long Island Jewish Research Institute Method for treating congestive heart failure
US20020183882A1 (en) * 2000-10-20 2002-12-05 Michael Dearing RF point of sale and delivery method and system using communication with remote computer and having features to read a large number of RF tags
US20030194437A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Cmax properties

Also Published As

Publication number Publication date
JP2006517588A (ja) 2006-07-27
WO2004071432A3 (en) 2005-03-10
AU2004211961A1 (en) 2004-08-26
NO20054034D0 (no) 2005-08-30
NO20054034L (no) 2005-10-05
WO2004071432A2 (en) 2004-08-26
EP1599193A2 (en) 2005-11-30
US20050176829A1 (en) 2005-08-11
CA2515400A1 (en) 2004-08-26
CO5650242A2 (es) 2006-06-30
EP1599193A4 (en) 2007-04-04
AU2004211961B2 (en) 2009-04-23
US20040156893A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
BR0316753A (pt) Método de tratamento para disfunção sexual
BRPI0415639A (pt) formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia
CY1106457T1 (el) Φαρμακευτικη συνθεση για τη χρηση σε θepαπεια ορμονικης υποκαταστασεως
EA200970237A1 (ru) Применение тенектеплазы для лечения острого ишемического инсульта
MXPA05007822A (es) Terapia de combinacion para tratar trastornos de la deficiencia de proteinas.
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
UY28376A1 (es) Agentes terapéuticos
MY127290A (en) New use of flibanserin
MXPA04008068A (es) Metodo para administrar moleculas de glp-1.
BR0211972A (pt) Composição oftálmica
CY1115286T1 (el) Μεθοδοι θεραπευτικης αγωγης της νοσου toy parkinson
BR0309117A (pt) Kit de inalação compreendendo pó inalável de tiotropium
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
EP1670450A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA
UY28144A1 (es) Agentes terapéuticos
CY1112284T1 (el) Ενωσεις τετραϋδροκυκλοπεντα[β] ινδολιου ως ρυθμιστες υποδοχεων ανδρογονων
MX2007004183A (es) Derivados de benzoimidazol utiles como agentes antiproliferacion.
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
WO2006128022A3 (en) Solid compositions and methods for treating middle-of-the night insomnia
BR0211830A (pt) Dose única de azitromicina
UY28377A1 (es) Agentes terapeuticos
NO20040598L (no) 5-CNAC som oralt avleveringsmiddel for paratyreoidhormonfragmenter.
BRPI0407410A (pt) método para o tratamento de hipotireoidismo
ECSP066865A (es) Dispositivo de distribución de fármacos visible por rayos x
BR0009380A (pt) Tratamento de câncer melhorado comtemozolomida

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.